price

NASDAQ · BDTX
Black Diamond Therapeutics, Inc.
Healthcare · Biotechnology
$1.94
Down-$0.01 (-0.52%)
Updated Sep 17, 2026, 9:01 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 158.11M
- P/E ratio
- 7.35
- Dividend yield
- 0.00%
- 52-week range
- $1.60 – $3.97
- Volume
- 733.91K
- Avg. volume
- 1.23M
Price performance
BDTX price history
1M range · 20 trading sessions · Daily adjusted prices
BDTX closed at $1.94 after 20 trading sessions, down 11.42% for the selected period.
- Last close
- $1.94
- Period change
- -11.42%
- Period low
- $1.94
- Period high
- $2.27
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.97 | $2.0067 | $1.915 | $1.94 | 733.91K |
| Sep 15, 2026 | $2.02 | $2.02 | $1.94 | $1.97 | 301.83K |
| Sep 14, 2026 | $1.98 | $2.04 | $1.97 | $2.03 | 514.16K |
| Sep 11, 2026 | $1.99 | $2.00 | $1.94 | $1.98 | 590.21K |
| Sep 10, 2026 | $2.06 | $2.06 | $1.92 | $1.96 | 677.92K |
| Sep 9, 2026 | $2.09 | $2.1492 | $2.065 | $2.10 | 402.59K |
| Sep 8, 2026 | $2.09 | $2.13 | $2.0719 | $2.10 | 370.04K |
| Sep 4, 2026 | $2.08 | $2.145 | $2.0609 | $2.12 | 324.72K |
| Sep 3, 2026 | $2.15 | $2.1655 | $2.06 | $2.10 | 609.84K |
| Sep 2, 2026 | $2.08 | $2.155 | $2.05 | $2.14 | 561.28K |
| Sep 1, 2026 | $2.09 | $2.11 | $2.02 | $2.04 | 759.13K |
| Aug 31, 2026 | $2.22 | $2.225 | $2.10 | $2.10 | 509.28K |
| Aug 28, 2026 | $2.28 | $2.29 | $2.17 | $2.23 | 522.04K |
| Aug 27, 2026 | $2.26 | $2.32 | $2.24 | $2.27 | 458.91K |
| Aug 26, 2026 | $2.21 | $2.29 | $2.16 | $2.27 | 491.29K |
| Aug 25, 2026 | $2.19 | $2.245 | $2.185 | $2.24 | 417.76K |
| Aug 24, 2026 | $2.22 | $2.22 | $2.13 | $2.155 | 345.32K |
| Aug 21, 2026 | $2.15 | $2.26 | $2.15 | $2.21 | 656.73K |
| Aug 20, 2026 | $2.17 | $2.19 | $2.08 | $2.15 | 1.14M |
| Aug 19, 2026 | $2.08 | $2.21 | $2.08 | $2.19 | 827.22K |
Latest BDTX news
The latest Smart Investors Daily articles mentioning BDTX.
Stock researchCompany · Financials
Loading stock research…

